Cell Death and Disease (Nov 2022)
Correction: TfR1 binding with H-ferritin nanocarrier achieves prognostic diagnosis and enhances the therapeutic efficacy in clinical gastric cancer
- Xiaojing Cheng,
- Kelong Fan,
- Lin Wang,
- Xiangji Ying,
- Andrew J. Sanders,
- Ting Guo,
- Xiaofang Xing,
- Meng Zhou,
- Hong Du,
- Ying Hu,
- Huirong Ding,
- Ziyu Li,
- Xianzi Wen,
- Wenguo Jiang,
- Xiyun Yan,
- Jiafu Ji
Affiliations
- Xiaojing Cheng
- Key Laboratory Carcinogenesis and Translational Research (Ministry of Education/Beijing), Division of Gastrointestinal Cancer Translational Research Laboratory, Peking University Cancer Hospital & Institute
- Kelong Fan
- Key Laboratory of Protein and Peptide Pharmaceutical, Chinese Academy of Sciences and University of Chinese Academy of Sciences
- Lin Wang
- Key Laboratory Carcinogenesis and Translational Research (Ministry of Education/Beijing), Division of Gastrointestinal Cancer Translational Research Laboratory, Peking University Cancer Hospital & Institute
- Xiangji Ying
- Key Laboratory Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Gastrointestinal Surgery, Peking University Cancer Hospital & Institute
- Andrew J. Sanders
- Cardiff China Medical Research Collaborative (CCMRC), Cardiff University School of Medicine, Heath Park
- Ting Guo
- Key Laboratory Carcinogenesis and Translational Research (Ministry of Education/Beijing), Division of Gastrointestinal Cancer Translational Research Laboratory, Peking University Cancer Hospital & Institute
- Xiaofang Xing
- Key Laboratory Carcinogenesis and Translational Research (Ministry of Education/Beijing), Division of Gastrointestinal Cancer Translational Research Laboratory, Peking University Cancer Hospital & Institute
- Meng Zhou
- Key Laboratory of Protein and Peptide Pharmaceutical, Chinese Academy of Sciences and University of Chinese Academy of Sciences
- Hong Du
- Key Laboratory Carcinogenesis and Translational Research (Ministry of Education/Beijing), Division of Gastrointestinal Cancer Translational Research Laboratory, Peking University Cancer Hospital & Institute
- Ying Hu
- Key Laboratory Carcinogenesis and Translational Research (Ministry of Education/Beijing) Department of Biobank, Peking University Cancer Hospital & Institute
- Huirong Ding
- Key Laboratory Carcinogenesis and Translational Research (Ministry of Education/Beijing), Division of Central Laboratory, Peking University Cancer Hospital & Institute
- Ziyu Li
- Key Laboratory Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Gastrointestinal Surgery, Peking University Cancer Hospital & Institute
- Xianzi Wen
- Key Laboratory Carcinogenesis and Translational Research (Ministry of Education/Beijing), Division of Gastrointestinal Cancer Translational Research Laboratory, Peking University Cancer Hospital & Institute
- Wenguo Jiang
- Cardiff China Medical Research Collaborative (CCMRC), Cardiff University School of Medicine, Heath Park
- Xiyun Yan
- Key Laboratory of Protein and Peptide Pharmaceutical, Chinese Academy of Sciences and University of Chinese Academy of Sciences
- Jiafu Ji
- Key Laboratory Carcinogenesis and Translational Research (Ministry of Education/Beijing), Division of Gastrointestinal Cancer Translational Research Laboratory, Peking University Cancer Hospital & Institute
- DOI
- https://doi.org/10.1038/s41419-022-05453-w
- Journal volume & issue
-
Vol. 13,
no. 11
pp. 1 – 2
Abstract
No abstracts available.
